In addition, it reduced IL-1β, IL-4, IL-6, IL-10, and IL-13 levels, down-regulated PI3K, ERK1/2, and up-regulated EGFR levels, improving the anti-tumor effects of the tumor suppressor microenvironment. The gene discussed is IL13; the disease is neoplasm.